OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5

What it is

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “olmesartan medoxomil, amlodipine and hydrochlorothiazide”, “olmesartan medoxomil amlodipine and hydrochlorothiazide”, “olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide” and “olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as tablet, film coated and its route as oral.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Camber Pharmaceuticals, Inc. and Macleods Pharmaceuticals Limited.

FDA lists it under 4 Established Pharmacologic Classes: Angiotensin 2 Receptor Blocker, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker and Thiazide Diuretic.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $23.29 for 30 tablets (30 × $0.77624 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 tablets · NADAC explanation codes

The 5 labelers

Other strengths, forms and brands

6 other products in the NADAC file share an FDA nonproprietary name with OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 8 NDCs’ NADAC prices is $0.77624 per EA filed.

Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 60 have a higher middle NADAC price and 47 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, at $1.15137 per EA filed (eff. 2026-09-23).

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 60 have a higher middle NADAC price and 47 a lower one. The one in the middle is DILTIAZEM 24H ER(LA) 240 MG TB, at $1.0087 per EA filed (eff. 2026-09-23).

Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 42 have a higher middle NADAC price and 25 a lower one. The one in the middle is ISRADIPINE 2.5 MG CAPSULE, at $1.13676 per EA filed (eff. 2026-09-23).

Of the 68 other products in FDA’s Thiazide Diuretic class priced per EA, 29 have a higher middle NADAC price and 39 a lower one. The one in the middle is TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, at $0.3567 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.